Chair’s Welcome

Welcome to the Department of Pharmacology, Physiology, and Neurobiology. This department incorporates two long-standing College of Medicine departments with strong histories of excellence at the University of Cincinnati. Our department is pursuing research initiatives exploring how organ systems interact to promote health and impact disease processes. Key areas of emphasis include cardiovascular biology, neurobiology, metabolic biology, chronobiology, computational biology, and membrane transport. We use systems biology and informatics to develop innovative new approaches for our research endeavors.

The department is committed to the training of the next generation of scientists, with PhD programs in the areas of pharmacology and physiology, and rigorous master’s programs geared toward preparing students for entry into the biomedical sciences workforce and enhancing competitiveness for medical school admissions. We look forward to a strong period of growth in both our research and education missions, and welcome you to consider joining us in this exciting time.

James P Herman, PhD
Flor van Maanen Professor and Chair

PPN Happenings

Congratulations to six PhD students!

Oct 2024 – Each student has received a travel award to attend a scientific conference. Details are here.

PhD candidate is first author on a review article

Oct 2024 – Alexander Kuhn and others in the Wohleb lab contributed a review of "Neuroimmunomodulation: the history of science in psychoneuroimmunology" to "Neuroimmunomodulation".

NIH award for PhD candidate Immaculeta Osuji

Oct 2024 – Congratulations to Immaculeta (Zimmermann lab) for her NIH F31 Predoctoral Fellowship Pathophysiological impact of subtypes of eosinophil cell death.

Dr. Wang and colleagues publish in "Environmental Health"

Sep 2024 – The team's report, Association of same-day urinary phenol levels and cardiac electrical alterations: analysis of the Fernald Community Cohort, received national attention.

Congratulations to Dr. McReynolds!

Oct 2024 – On the basis of her R01 application, she received a seven-year Early Stage Investigator Merit award from NIH/NIDA. This reflects the esteem with which she is held by NIDA leadership.

Latest News

New brain stimulation trial aims to improve cognitive recovery from TBI

12/13/2024

New brain stimulation trial aims to improve cognitive recovery from TBI Full Story

What might happen with immigration policies in the new year?

12/13/2024

What might happen with immigration policies in the new year? Full Story